Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "AREA[SponsorSearch](Beijing Cancer Hospital)"
Count: 310
Selected: 0
| NCT ID | Title |
|---|
| NCT03389438 | Autologous Cellular Immunotherapy in Patients With Metastatic Bladder Urothelial Carcinoma | ||
| NCT03051581 | 18F-FDG PET/CT-based Prognostic Model for Predicting Outcome in Patients With Peripheral T-cell Lymphoma | ||
| NCT03051568 | Evaluating 18F-FDG PET/CT With Liver SUVmax-based Criteria for Prognosis of Patients With Peripheral T-cell Lymphoma | ||
| NCT03051555 | 18F-FDG PET/CT-based Prognostic Model for Predicting Outcome in Patients With Natural Killer/T-cell Lymphoma | ||
| NCT03051542 | Evaluating 18F-FDG PET/CT With Liver SUVmax-based Criteria for Prognosis of Patients With Natural Killer/T-cell Lymphoma | ||
| NCT02942043 | Bevacizumab in the Treatment of Malignant Pleural Effusions of Non-squamous Non-small Cell Lung Cancer | ||
| NCT03199989 | Efficacy of Postoperative Adjuvant Chemotherapy for Stage II Colon Cancer With High Risk Factors(EPAC1) | ||
| NCT03708978 | Development of Artificial Intelligence System for Detection and Diagnosis of Breast Lesion Using Mammography | ||
| NCT02159339 | DNA Methylation Biomarkers and Metastasis of Gastric Carcinoma | ||
| NCT03031444 | Perioperative Chemotherapy Plus Cetuximab Versus Chemotherapy Alone for High Risk Resectable Colorectal Liver Metastasis | ||
| NCT02878057 | Multicenter Phase II Study of Apatinib in Patients With Advanced Breast Cancer(CABC006) | ||
| NCT05000372 | 68Ga-grazytracer PET/CT in Subjects With Non-small Cell Lung Cancer or Melanoma | ||
| NCT04596670 | 68Ga-ICAM-1pep PET/CT in Cancer Patients | ||
| NCT01661218 | Complications and Risk Factors Related With Central Venous Catheters in Cancer Patients | ||
| NCT02464215 | Effect of Laparoscopy-Assisted Distal Gastrectomy for Locally Advanced Gastric Cancer | ||
| NCT03448549 | SOX Versus XELOX as Adjuvant Chemotherapy for Stage III Colorectal Cancer Patients | ||
| NCT04303130 | Camrelizumab Combined With Endostar for First-line Treatment in Subjects With Advanced Squamous NSCLC | ||
| NCT02500810 | Monosialoganglioside Preventing Neurotoxicity Induced by Albumin-bound Paclitaxel Chemotherapy in Lung Cancer Patients | ||
| NCT03286920 | Effect of Postoperative Family Nutrition Mode on Weight/BMI of Patients With Esophageal Cancer | ||
| NCT03528421 | Assessment of Safety and Efficacy of IM19 for Relapsed or Refractory NHL Patients | ||
| NCT03454919 | Efficacy of Palbociclib in Advanced Acral Melanoma With Cell Cycle Gene Aberrations | ||
| NCT02937467 | The Multi-Center Study of Shear Wave Elastography on Thyroid Nodules | ||
| NCT05685914 | Outcomes of Endoscopic Operation in COVID-19 Infection: Cohort Study. | ||
| NCT05656144 | Cadonilimab in the Treatment of Advanced Soft Tissue Sarcoma | ||
| NCT05590221 | Relmacabtagene Autoleucel as First-Line Therapy for High-Risk Large B-Cell Lymphoma | ||
| NCT05579275 | A Study to Evaluate the Safety and Tolerability of JCXH-212 Injection in the Treatment of Advanced Malignant Solid Tumors | ||
| NCT05577442 | Trastuzumab, Pyrotinib Combined With Dalpiciclib and Endocrine Therapy for HR +/HER2 + Advanced Breast Cancer | ||
| NCT05529615 | Circulating Tumor DNA Guided Adjuvant Chemotherapy for Colon Cancer | ||
| NCT05512481 | Camrelizumab Plus Apatinib and Temozolomide as Neoadjuvant in High Risk Acral Melanoma | ||
| NCT05478473 | Clinical Study of Chidamide Combined With Toripalimab in the Treatment of Advanced Melanoma | ||
| NCT05436093 | CLDN18.2 Targeting Nanobody Probe for PET Imaging in Solid Tumors | ||
| NCT05411250 | Early Diagnosis of Therapy-associated Cardiotoxicity Basing on PET/CT in Lymphoma | ||
| NCT05406206 | Hepatic Arterial Infusion Chemotherapy With Fruquintinib for Colorectal Cancer Liver Metastases As Third-line Therapy | ||
| NCT05390632 | Head-to-head Comparison Between [18F]-FDG PET/CT and PET/MRI in Lymphomas | ||
| NCT05380024 | A Study of Ensartinib as Neoadjuvant Therapy for Patients With ALK Positive Resectable Non-Small Cell Lung Cancer | ||
| NCT05374044 | Establishment of MRI Model for pTRG in Rectal Cancer With Establishment of | ||
| NCT05322512 | Nectin-4 Targeting ADC Probe for PET Imaging in Solid Tumors | ||
| NCT05321316 | Nectin-4 Specific LMW PET Probe Imaging in Urothelial Carcinoma | ||
| NCT05274438 | Imatinib and Toripalimab in Patients With Locally Advanced/Metastatic Melanoma Harbored With CKIT Mut | ||
| NCT05229029 | RSYR for Fatigue Reduction in Cancer Fatigue Caused by Chemotherapy | ||
| NCT05188495 | Trastuzumab(Henlius®) Combined With Pertuzumab(Perjeta®) and Chemotherapy in Chinese Patients With Her2-Positive Metastatic Breast Cancer Previously Treated With Trastuzumab | ||
| NCT05156515 | PD-L1 Targeting Nanobody Probe for PET Imaging of Solid Tumor | ||
| NCT05132218 | Ensatinib in alK-positive Patients Undergoing Initial Treatment for Advanced Non-small Cell Lung Cancer | ||
| NCT05104801 | Sitravatinib With or Without Tislelizumab in Patients With Unresectable or Metastatic Melanoma | ||
| NCT05104788 | A Study of Icotinib With Chemotherapy as Neoadjuvant Therapy for Patients With EGFRm Positive Resectable Non-Small Cell Lung Cancer | ||
| NCT05070221 | Study of Oncolytic Virus in Combination With HX-008 and Axitinib in Melanoma Patients With Liver Metastasis | ||
| NCT05068453 | Study of Oncolytic Virus in Combination With HX-008 and Radiotherapy in Melanoma Patients With Liver Metastasis | ||
| NCT05051865 | To Explore the Efficacy and Safety of Camrelizumab Combined With SHR1020 in the Treatment of Advanced Melanoma | ||
| NCT05025592 | cTACE or DEB-TACE+HAIC Combined With Regorafenib ± Anti-PD1 Antibody for uHCC | ||
| NCT05004961 | The Performance of Multi-tracer Multimodality PET in Lymphoma |
